Activation of p38 MAPK is required in monocytic and neuronal cells for HIV glycoprotein 120-induced neurotoxicity

Journal of Immunology

Volumn 185, Issue 8, 2010, Pages 4883-4895

  Medders, Kathryn E ^a,b   Sejbuk, Natalia E ^a   Maung, Ricky ^a   Desai, Maya K ^a   Kaul, Marcus ^a,c  

^a BURNHAM INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON TETRACHLORIDE; CHEMOKINE RECEPTOR CCR5; GLYCOPROTEIN GP 120; MITOGEN ACTIVATED PROTEIN KINASE P38; MITOGEN ACTIVATED PROTEIN KINASE P38 INHIBITOR; NEUROTOXIN; SMALL INTERFERING RNA; GP120 PROTEIN, HUMAN IMMUNODEFICIENCY VIRUS 1;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CULTURE; HUMAN IMMUNODEFICIENCY VIRUS; MACROPHAGE; MICROGLIA; MONOCYTE; MUTANT; NERVE CELL; NERVE CELL NECROSIS; NEUROTOXICITY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; SUPERNATANT; ANIMAL; BIOSYNTHESIS; ENZYME ACTIVATION; FLUORESCENT ANTIBODY TECHNIQUE; HUMAN; IMMUNOBLOTTING; METABOLISM; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; CELLS, CULTURED; ENZYME ACTIVATION; FLUORESCENT ANTIBODY TECHNIQUE; HIV ENVELOPE PROTEIN GP120; HUMANS; IMMUNOBLOTTING; MONOCYTES; NEURONS; NEUROTOXINS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION;

EID: 78049512509     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0902535     Document Type: Article

References (49)

1. Antinori, A., G. Arendt, J. T. Becker, B. J. Brew, D. A. Byrd, M. Cherner, D. B. Clifford, P. Cinque, L. G. Epstein, K. Goodkin, et al. 2007. Updated research nosology for HIV-associated neurocognitive disorders. Neurology 69:1789-1799.
2. Koenig, S., H. E. Gendelman, J. M. Orenstein, M. C. Dal Canto, G. H. Pezeshkpour, M. Yungbluth, F. Janotta, A. Aksamit, M. A. Martin, and A. S. Fauci. 1986. Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy. Science 233:1089-1093.
3. Porcheray, F., B. Samah, C. Léone, N. Dereuddre-Bosquet, and G. Gras. 2006. Macrophage activation and human immunodeficiency virus infection: HIV replication directs macrophages towards a pro-inflammatory phenotype while previous activation modulates macrophage susceptibility to infection and viral production. Virology 349:112-120.
4. González-Scarano, F., and J. Martín-García. 2005. The neuropathogenesis of AIDS. Nat. Rev. Immunol. 5:69-81.
5. Kaul, M., G. A. Garden, and S. A. Lipton. 2001. Pathways to neuronal injury and apoptosis in HIV-associated dementia. Nature 410:988-994.
6. Masliah, E., N. Ge, C. L. Achim, L. A. Hansen, and C. A. Wiley. 1992. Selective neuronal vulnerability in HIV encephalitis. J. Neuropathol. Exp. Neurol. 51:585-593.
7. Masliah, E., R. K. Heaton, T. D. Marcotte, R. J. Ellis, C. A. Wiley, M. Mallory, C. L. Achim, J. A. McCutchan, J. A. Nelson, J. H. Atkinson, I. Grant; HNRC Group. The HIV Neurobehavioral Research Center. 1997. Dendritic injury is a pathological substrate for human immunodeficiency virus-related cognitive disorders. Ann. Neurol. 42:963-972.
8. Glass, J. D., H. Fedor, S. L. Wesselingh, and J. C. McArthur. 1995. Immunocytochemical quantitation of human immunodeficiency virus in the brain: correlations with dementia. Ann. Neurol. 38:755-762.
9. Adle-Biassette, H., F. Chrétien, L. Wingertsmann, C. Héry, T. Ereau, F. Scaravilli, M. Tardieu, and F. Gray. 1999. Neuronal apoptosis does not correlate with dementia in HIV infection but is related to microglial activation and axonal damage. Neuropathol. Appl. Neurobiol. 25:123-133.
10. Singh, I. N., N. El-Hage, M. E. Campbell, S. E. Lutz, P. E. Knapp, A. Nath, and K. F. Hauser. 2005. Differential involvement of p38 and JNK MAP kinases in HIV-1 Tat and gp120-induced apoptosis and neurite degeneration in striatal neurons. Neuroscience 135:781-790.
11. Shi, B., U. De Girolami, J. He, S. Wang, A. Lorenzo, J. Busciglio, and D. Gabuzda. 1996. Apoptosis induced by HIV-1 infection of the central nervous system. J. Clin. Invest. 98:1979-1990.
12. Giulian, D., E. Wendt, K. Vaca, and C. A. Noonan. 1993. The envelope glycoprotein of human immunodeficiency virus type 1 stimulates release of neurotoxins from monocytes. Proc. Natl. Acad. Sci. USA 90:2769-2773.
13. Toggas, S. M., E. Masliah, E. M. Rockenstein, G. F. Rall, C. R. Abraham, and L. Mucke. 1994. Central nervous system damage produced by expression of the HIV-1 coat protein gp120 in transgenic mice. Nature 367:188-193.
14. Meucci, O., A. Fatatis, A. A. Simen, T. J. Bushell, P. W. Gray, and R. J. Miller. 1998. Chemokines regulate hippocampal neuronal signaling and gp120 neurotoxicity. Proc. Natl. Acad. Sci. USA 95:14500-14505.
15. Kaul, M., and S. A. Lipton. 1999. Chemokines and activated macrophages in HIV gp120-induced neuronal apoptosis. Proc. Natl. Acad. Sci. USA 96:8212-8216.
16. Kaul, M., Q. Ma, K. E. Medders, M. K. Desai, and S. A. Lipton. 2007. HIV-1 coreceptors CCR5 and CXCR4 both mediate neuronal cell death but CCR5 paradoxically can also contribute to protection. Cell Death Differ. 14:296-305.
17. Hesselgesser, J., D. Taub, P. Baskar, M. Greenberg, J. Hoxie, D. L. Kolson, and R. Horuk. 1998. Neuronal apoptosis induced by HIV-1 gp120 and the chemokine SDF-1 alpha is mediated by the chemokine receptor CXCR4. Curr. Biol. 8:595-598.
18. Hesselgesser, J., M. Halks-Miller, V. DelVecchio, S. C. Peiper, J. Hoxie, D. L. Kolson, D. Taub, and R. Horuk. 1997. CD4-independent association between HIV-1 gp120 and CXCR4: functional chemokine receptors are expressed in human neurons. Curr. Biol. 7:112-121.
19. O'Donnell, L. A., A. Agrawal, K. L. Jordan-Sciutto, M. A. Dichter, D. R. Lynch, and D. L. Kolson. 2006. Human immunodeficiency virus (HIV)-induced neurotoxicity: roles for the NMDA receptor subtypes. J. Neurosci. 26:981-990.
20. Cheung, R., V. Ravyn, L. Wang, A. Ptasznik, and R. G. Collman. 2008. Signaling mechanism of HIV-1 gp120 and virion-induced IL-1beta release in primary human macrophages. J. Immunol. 180:6675-6684.
21. Garden, G. A., W. Guo, S. Jayadev, C. Tun, S. Balcaitis, J. Choi, T. J. Montine, T. Möller, and R. S. Morrison. 2004. HIV associated neurodegeneration requires p53 in neurons and microglia. FASEB J. 18:1141-1143.
22. Cocchi, F., A. L. DeVico, A. Garzino-Demo, S. K. Arya, R. C. Gallo, and P. Lusso. 1995. Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells. Science 270:1811-1815.
23. Kerr, S. J., P. J. Armati, L. A. Pemberton, G. Smythe, B. Tattam, and B. J. Brew. 1997. Kynurenine pathway inhibition reduces neurotoxicity of HIV-1-infected macrophages. Neurology 49:1671-1681.
24. Zheng, J., A. Ghorpade, D. Niemann, R. L. Cotter, M. R. Thylin, L. Epstein, J. M. Swartz, R. B. Shepard, X. Liu, A. Nukuna, and H. E. Gendelman. 1999. Lymphotropic virions affect chemokine receptor-mediated neural signaling and apoptosis: implications for human immunodeficiency virus type 1-associated dementia. J. Virol. 73:8256-8267.
25. Del Corno, M., Q. H. Liu, D. Schols, E. de Clercq, S. Gessani, B. D. Freedman, and R. G. Collman. 2001. HIV-1 gp120 and chemokine activation of Pyk2 and mitogen-activated protein kinases in primary macrophages mediated by calciumdependent, pertussis toxin-insensitive chemokine receptor signaling. Blood 98:2909-2916.
26. Fantuzzi, L., F. Spadaro, C. Purificato, S. Cecchetti, F. Podo, F. Belardelli, S. Gessani, and C. Ramoni. 2008. Phosphatidylcholine-specific phospholipase C activation is required for CCR5-dependent, NF-kB-driven CCL2 secretion elicited in response to HIV-1 gp120 in human primary macrophages. Blood 111:3355-3363.
27. Perfettini, J. L., M. Castedo, R. Nardacci, F. Ciccosanti, P. Boya, T. Roumier, N. Larochette, M. Piacentini, and G. Kroemer. 2005. Essential role of p53 phosphorylation by p38 MAPK in apoptosis induction by the HIV-1 envelope. J. Exp. Med. 201:279-289.
28. Ono, K., and J. Han. 2000. The p38 signal transduction pathway: activation and function. Cell. Signal. 12:1-13.
29. Johnson, G. V., and C. D. Bailey. 2003. The p38 MAP kinase signaling pathway in Alzheimer's disease. Exp. Neurol. 183:263-268.
30. Barone, F. C., E. A. Irving, A. M. Ray, J. C. Lee, S. Kassis, S. Kumar, A. M. Badger, J. J. Legos, J. A. Erhardt, E. H. Ohlstein, et al. 2001. Inhibition of p38 mitogen-activated protein kinase provides neuroprotection in cerebral focal ischemia. Med. Res. Rev. 21:129-145.
31. Barber, S. A., J. L. Uhrlaub, J. B. DeWitt, P. M. Tarwater, and M. C. Zink. 2004. Dysregulation of mitogen-activated protein kinase signaling pathways in simian immunodeficiency virus encephalitis. Am. J. Pathol. 164:355-362.
32. Choi, W. T., M. Kaul, S. Kumar, J. Wang, I. M. Kumar, C. Z. Dong, J. An, S. A. Lipton, and Z. Huang. 2007. Neuronal apoptotic signaling pathways probed and intervened by synthetically and modularly modified (SMM) chemokines. J. Biol. Chem. 282:7154-7163.
33. Kaul, M., and M. Loos. 1995. Collagen-like complement component C1q is a membrane protein of human monocyte-derived macrophages that mediates endocytosis. J. Immunol. 155:5795-5802.
34. Terheyden, P., M. Loos, S. Störkel, and M. Kaul. 2005. Human macrophages simultaneously express membrane-C1q and Fc-receptors for IgG. Immunol. Lett. 101:202-209.
35. Kaplan, G., and G. Gaudernack. 1982. In vitro differentiation of human monocytes. Differences in monocyte phenotypes induced by cultivation on glass or on collagen. J. Exp. Med. 156:1101-1114.
36. Giulian, D., K. Vaca, and C. A. Noonan. 1990. Secretion of neurotoxins by mononuclear phagocytes infected with HIV-1. Science 250:1593-1596.
37. Zhao, M., L. New, V. V. Kravchenko, Y. Kato, H. Gram, F. di Padova, E. N. Olson, R. J. Ulevitch, and J. Han. 1999. Regulation of the MEF2 family of transcription factors by p38. Mol. Cell. Biol. 19:21-30.
38. Lee, J. C., S. Kassis, S. Kumar, A. Badger, and J. L. Adams. 1999. p38 mitogenactivated protein kinase inhibitors-mechanisms and therapeutic potentials. Pharmacol. Ther. 82:389-397.
39. Davies, S. P., H. Reddy, M. Caivano, and P. Cohen. 2000. Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem. J. 351:95-105.
40. He, J., Y. Chen, M. Farzan, H. Choe, A. Ohagen, S. Gartner, J. Busciglio, X. Yang, W. Hofmann, W. Newman, et al. 1997. CCR3 and CCR5 are coreceptors for HIV-1 infection of microglia. Nature 385:645-649.
41. Ohagen, A., S. Ghosh, J. He, K. Huang, Y. Chen, M. Yuan, R. Osathanondh, S. Gartner, B. Shi, G. Shaw, and D. Gabuzda. 1999. Apoptosis induced by infection of primary brain cultures with diverse human immunodeficiency virus type 1 isolates: evidence for a role of the envelope. J. Virol. 73:897-906.
42. Kitai, R., M. L. Zhao, N. Zhang, L. L. Hua, and S. C. Lee. 2000. Role of MIP-1beta and RANTES in HIV-1 infection of microglia: inhibition of infection and induction by IFNbeta. J. Neuroimmunol. 110:230-239.
43. Lee, C., Q. H. Liu, B. Tomkowicz, Y. Yi, B. D. Freedman, and R. G. Collman. 2003. Macrophage activation through CCR5-and CXCR4-mediated gp120-elicited signaling pathways. J. Leukoc. Biol. 74:676-682.
44. Missé, D., P. O. Esteve, B. Renneboog, M. Vidal, M. Cerutti, Y. St Pierre, H. Yssel, M. Parmentier, and F. Veas. 2001. HIV-1 glycoprotein 120 induces the MMP-9 cytopathogenic factor production that is abolished by inhibition of the p38 mitogen-activated protein kinase signaling pathway. Blood 98:541-547.
45. Mueller, A., N. G. Mahmoud, M. C. Goedecke, J. A. McKeating, and P. G. Strange. 2002. Pharmacological characterization of the chemokine receptor, CCR5. Br. J. Pharmacol. 135:1033-1043. (Pubitemid 34214463)
46. Oppermann, M. 2004. Chemokine receptor CCR5: insights into structure, function, and regulation. Cell. Signal. 16:1201-1210.
47. Kim, C., Y. Sano, K. Todorova, B. A. Carlson, L. Arpa, A. Celada, T. Lawrence, K. Otsu, J. L. Brissette, J. S. Arthur, and J. M. Park. 2008. The kinase p38 alpha serves cell type-specific inflammatory functions in skin injury and coordinates pro-and anti-inflammatory gene expression. Nat. Immunol. 9:1019-1027.
48. Kang, Y. J., J. Chen, M. Otsuka, J. Mols, S. Ren, Y. Wang, and J. Han. 2008. Macrophage deletion of p38alpha partially impairs lipopolysaccharide- induced cellular activation. J. Immunol. 180:5075-5082.
49. Munoz, L., H. R. Ranaivo, S. M. Roy, W. Hu, J. M. Craft, L. K. McNamara, L. W. Chico, L. J. Van Eldik, and D. M. Watterson. 2007. A novel p38 alpha MAPK inhibitor suppresses brain proinflammatory cytokine up-regulation and attenuates synaptic dysfunction and behavioral deficits in an Alzheimer's disease mouse model. J. Neuroinflammation 4:21.